Immune Modulatory DC Vaccine Against Brain Tumor

Clinical trial NCT03914768 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT03914768
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: ENROLLING_BY_INVITATION
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Intrinsic Pontine Glioma or Glioblastoma

Start date: 2026-05-31
Primary completion: 2029-05-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.